We investigated the effects of resistance exercise combined with essential amino acid supplementation on psoas major muscle (PMM) hypertrophy and walking ability in elderly individuals. Twenty-nine healthy elderly individuals were assigned to 3 groups: (1) E (exercise), (2) A3 (exercise combined with 3.0 g of essential amino acid supplementation), and (3) A6 (exercise combined with 6.0 g of essential amino acid supplementation). To evaluate walking ability, the participants underwent the following 3 types of tests: the (1) 10-meter walk (10-W), (2) 10-meter walk involving crossing of obstacles (10-W + O), and (3) 6-minute walk (6M-W) tests. The 6-month training program resulted in signifi cant PMM hypertrophy in all groups independent of amino acid supplementation. The extent of hypertrophy in the participants who took amino acids was dose-dependent, although the differences were not signifi cant. Groups A3 and A6 demonstrated improvements in the 10-W and 10-W + O tests, whereas no improvement was observed in group E, regardless of PMM hypertrophy. Furthermore, group A6 showed an improvement in the 6M-W test. These results suggest that our training program causes PMM hypertrophy, whereas the training program combined with essential amino acid supplementation improves walking ability.
As individuals age, involuntary loss in skeletal muscle mass and strength (sarcopenia) occurs, primarily between 50 and 70 years of age, with the decrease amounting to 15% per decade (1, 2, 15, 24) . The degree of muscle atrophy and its functional impairment is more severe in the lower limbs than in the upper limbs (3, 11, 14) , which presumably leads to walking disabilities. With aging, the frequency of falling during every day physical activities such as walking and climbing stairs increases. Walking ability is considered to refl ect the physiological functioning of various organ systems such as the cardiovascular and neuromuscular systems. It has been reported that walking speed is an index of survival in older people (9, 21) . Therefore, a training program to improve walking ability may be benefi cial for improving the quality of life and survival of older people.
A nutritional approach to enhance the effects of the training program is important. In particular, amino acid supplementation is considered quite useful. Nutritional supplementation with the 9 essential amino acids in particular has been shown to accelerate recovery from muscle fatigue after high-intensity resistance exercise, although the quantity and composition of these amino acids varied between studies (17, 22) . It has also been reported that nutritional supplementation with a mixture of essential amino acids increases muscle protein synthesis in older individuals (6) . We hypothesized that exercise combined with essential amino acid supplementation would therefore enhance improvement in walking ability in older individuals.
The current study also focused on the psoas major muscle (PMM). Although various muscles are important for walking and climbing stairs, PMM, the largest hip-fl exor muscle, plays a crucial role in raising the leg and stabilizing the body during these movements (16) . It has also been reported that PMM is a key muscle during sprint running because it contributes to fast and forceful hip joint-fl exion and the extension cycle that produces running speed (8) . However, whether PMM infl uences walking ability signifi cantly remains unknown. Ikezoe et al. reported no signifi cant difference in the thickness of PMM between fast-walking (maximum walking speed > 1 m/s) and slow-walking (maximum walking speed < 1 m/s) elderly groups (10) . Although their study implied that the thickness of PMM does not contribute signifi cantly to walking speed in elderly individuals, some participants in both groups walked with assistive devices. Therefore, it is unclear whether exercise-induced PMM hypertrophy contributes to the degree of improvement in walking ability.
On the basis of the results of previous studies, this study aimed to evaluate if resistance exercise combined with essential amino acid supplementation improved the walking ability of elderly people and to determine whether exercise-induced hypertrophy of PMM contributed signifi cantly to improvements in walking ability.
Materials and Methods

Experimental approach to the problem
Because various types of exercises were performed and walking tests were conducted in this study, we excluded those elderly people who could not walk without assistive devices. In addition, to evaluate the effects of essential amino acid supplementation combined with resistance exercise, we also excluded elderly people with nutritional defi ciencies. It has been reported that the total daily energy expenditure of Japanese healthy elderly individuals is 1876 ± 368 (mean ± SD) kcal/day (23) . As the age and body weight of the participants in this study were nearly the same as in the above-mentioned study (23), we excluded elderly people whose total daily caloric intake was 2 standard deviation (SD) < 1876 kcal/day (1140 kcal/ day). For practical applications regarding the results from this study, the diet schedules of the participants were nearly identical to their normal schedules. Participants were included in this study on the basis of their responses to a physical health questionnaire developed to determine their health status. We excluded participants with heart and skeletal muscle conditions such as arrhythmias, muscle strains, and muscle tears, other conditions such as infections and tendon diseases, and diet supplements that may have interfered with our experiments such as any amino acid and protein tablets or powders. In this study, lowintensity resistance exercise was performed with a short rest period. Although it is usually recommended that high-load resistance exercise (> 70% of 1 repetition maximum) be performed to induce skeletal muscle hypertrophy and increase muscle strength (19) , these high-intensity exercises may pose a risk for injury in elderly people. It has been demonstrated that high-volume with low-load resistance exercise (30% of 1 repetition maximum) can induce signifi cant muscle protein synthesis (4) . The elderly participants in this study preferred not to perform high-intensity resistance exercise, and therefore, we used a low-intensity resistance exercise program.
Participants
Initially, a total of 39 healthy elderly individuals participated in this study and were assigned randomly to the following 3 groups: (1) E (exercise: 6 males, 7 females), (2) A3 (exercise combined with 3.0 g of essential amino acid supplementation: 5 males, 8 females), and (3) A6 (exercise combined with 6.0 g of essential amino acid supplementation: 5 males, 8 females). All participants completed a physical activity questionnaire that was administered according to the guidelines of the Ministry of Health, Labour and Welfare of Japan for preventing the metabolic syndrome. To prevent the metabolic syndrome, the Ministry of Health, Labour, and Welfare of Japan recommends > 23 exercises/week (1 exercise is equivalent to 3 METs × 20 min). The physical activity level of the participants in this study was > 23 exercises/week. Before assigning the participants to the 3 groups, a 1-week questionnaire on daily food consumption was obtained from the participants and their nutrient intake habits analyzed by nutrition experts (18) . We confi rmed that the 3 groups were nearly identical in terms of nutrient intake (Table I) . We instructed the participants to continue their normal diet schedules throughout the experiment period. Four males and 6 females withdrew from the study for personal reasons, resulting in a total of 29 healthy elderly individuals completing the investigations. The characteristics of these 29 participants are shown in Table  II . Their group assignments were as follows: (1) E (4 males and 4 females); (2) A3 (5 males and 5 females), and (3) A6 (3 males and 8 females). All experimental procedures were performed in accordance with the guidelines of the Declaration of Helsinki. The participants were fully informed regarding the study procedures, experimental risks, and purpose of the study. All participants signed informed consent forms, which were approved prior to the study by the Human Subject Research Committee of the University of Tokyo. Values are expressed as means ± standard deviations (SD). The data of participants who withdrew from the study were excluded from this data. Because no signifi cant differences in quantity of food intake were observed between male and female participants, the data for males and females were combined Kawada S et al. Values are expressed as means ± SD. The data of age and height were collected before the experiment. Body weight was measured throughout the experiment. n = 8 for group E (4 males and 4 females); n = 10 for group A3 (5 males and 5 females); n = 11 for group A6 (3 males and 8 females) Table III . Exercise regimen
Types of exercises Intensity
Standing cycle ergometer A 10 min at < 100 watt
Standing cycle ergometer B 10 min at < 100 watt
Standing cycle ergometer C 10 min at < 100 watt 
Training program
Participants trained twice a week for 6 months in training classes conducted at the University of Tokyo. They were supervised by experienced fi tness instructors during the exercise sessions. When participants came to the university, this was recorded on a check-in sheet and they were asked about their physical conditions. Study investigators subsequently confi rmed their compliance with the training sessions. Table III shows the exercise program for the entire body, which included exercises for improving walking ability and strengthening large muscle groups. To improve walking ability, 3 types of specifi c standing cycle ergometers (Spowell Co., Shizuoka, Japan) were employed (Fig. 1) . The participants exercised on each cycle ergometer at < 100 W for 10 min at their own pace in a manner that increased their heart rate to < 100 beats per minute. To increase muscle strength and endurance, 9 types of isotonic exercise machines were used. The standing push-and-pull and trunk-twisting machines were obtained from Spowell and the others from Seno Co., Chiba, Japan. The exercises were carried out for a maximum of 30 repetitions (20-30 repetitions × 2 sets), with a 1-min rest period between training sets (Table III) . Before and after each exercise training session, the participants performed warm-up exercises including dynamic stretching and a cool-down including static stretching exercises. Each training session was performed at the same time of day (13:30-15:30).
Supplementation program
Two participant groups received essential amino acid supplementations. One day before the fi rst training session, group A3 was administered 3 g of powder containing 9 essential amino acids (Ajinomoto Co., Inc., Tokyo Japan) with milk (180 mL) once daily during breakfast throughout the experimental period. Group A6 was administered the same powder twice daily, during breakfast and dinner. Three grams of the amino acid powder included leucine (1200 mg), lysine (500 mg), valine (330 mg), isoleucine (320 mg), threonine (280 mg), phenylalanine (200 mg), methionine (100 mg), histidine (50 mg), and tryptophan (20 mg). Group E was administered 3 g of powder containing dextrin with milk once daily during breakfast, as a placebo. All participants habitually drank milk every day, and the quantity consumed was nearly identical in all the groups. The participants were therefore instructed to consume the supplements with milk. When the supplementation was administered, the participants recorded this on a check sheet. Study investigators subsequently confi rmed the compliance of the participants with their supplementation programs. This supplementation program was performed as a single-blinded study.
Evaluation of walking ability
To evaluate walking ability, the participants underwent 3 types of tests: (1) 10-meter walk (10-W), (2) 10-meter walk with obstacle crossing (10-W + O), and (3) 6-min walk (6M-W).
For the 10-W test, the participants walked for 10 m on a fl at surface at his/her maximal speed, and the time recorded with a stopwatch. For the 10-W + O test, the participants walked at his/ Fig. 1 . Three types of standing cycle ergometers. During exercise, the participants supported themselves using gripping bars. It was acceptable to move the foot axels 30 cm back and forth during exercise (A and B). The foot axels of the machine were moved back and forth electrically during exercise so that the walking speed of the participants was regulated (C). The step length was set for individual participants (height -100 cm)
her maximal speed across a 10-m fl oor on which 6 obstacles had been placed (20 cm in height, 10 cm in thickness) at intervals of 2 m, including a start point and goal point. For the 6M-W test, a 100-m lane was marked out on a fi eld and the participants walked at his/her own pace and covered as much ground as possible in 6 min. During this test, they were given verbally encouragement such as "you are doing well" or "keep up the good work". At the end of this test, the total distance covered was measured. On a different day before the fi rst walking tests, the participants were familiarized with the measurement procedures. Each walking test was conducted at the same time of day (13:30-15:30) to decrease the effects of any diurnal variations on physical activity. On the testing day, the participants fi rst performed a warm-up, including slow-walking (< 1 m/s) for 5 min as well as dynamic stretching, followed by the walking tests.
Magnetic resonance imaging (MRI)
MRI of the trunk was performed using a 1.5-T scanner (MRT-2003/P3, Toshiba Medical Systems Co., Tochigi, Japan) with a body coil to determine the cross-sectional area (CSA) of both sides of PMM. After longitudinal scans were taken to identify the position of the lumbar vertebrae, a transverse image of 10-mm thickness (repetition time, 250 ms; echo time, 20 ms; matrix, 224 × 128; fi eld of view, 30 × 30 cm; 4 number of excitations) at the mid-level between the fourth and fi fth lumbar vertebrae was scanned. The images obtained were traced using a computer mouse, and the CSAs calculated by adding the pixels of the enclosed regions. Intra-observer differences in calculation of the muscle CSAs were determined in a pilot study by carrying out triplicate measurements in 3 participants. The coeffi cient of variation for each CSA measurement was < 1%. The total CSA of the right and left sides was calculated. Images were obtained before and after 3 and 6 months of the training period. The post-training measurements were taken within 1 week after the fi nal training session.
Statistical analyses
The data of the participants who withdrew from the study were excluded from the data analyses. Values were expressed as mean ± standard deviation (SD). Data were examined using a 3 (condition) × 3 (time of measurement) repeated-measures analysis of variance for interaction and main effects. When a statistical signifi cance was obtained, the Fisher's protected least signifi cant difference post-hoc test was used for comparisons between the 3 groups. All data were examined using Stat View 5.0 for Windows (SAS Institute Inc., Cary, NC, USA). An alpha level of P < 0.05 was considered statistically signifi cant for all comparisons.
Results
Prior to the study, walking speed in group E was 2.36 ± 0.42 m/s (mean ± SD); group A3 was 2.53 ± 0.32 m/s; group A6 was 2.51 ± 0.32 m/s. These values were calculated from the results of the 10-W test. No signifi cant difference was observed between the groups. Mean habitual nutrient intake was roughly similar in the 3 groups (Table I) . Body weights did not change throughout the experimental period in any of the groups (Table II) . Because the percentage changes in body weight in the males and females in all the groups were almost the same, the data of male and female body weights were combined, as shown in Table II . Increases in PMM CSA (percentage changes) occurred after the 6-month exercise program in all the groups independent of amino acid supplementation (Table IV) . The extent of hypertrophy changes was not signifi cantly different between the 3 groups. Although the absolute PMM CSA in the male participants was signifi cantly greater than that in the female participants in all groups (data not shown), no difference in the percentage changes in PMM hypertrophy was found between the male and female participants. Therefore, the PMM data of male and female participants were combined, as shown in Table IV . Groups A3 (-13.2% ± 9.4%) and A6 (-13.5% ± 9.2%) showed improvements in the 10-W test at 6 months (condition × time interactions were not observed), whereas group E showed no signifi cant change (Table IV) . Groups A3 (-9.8% ± 7.2% at 3 months; -13.6% ± 8.6% at 6 months) and A6 (-12.7% ± 6.6% at 3 months; -16.9% ± 7.2% at 6 months) showed improvements in the 10-W + O test after the exercise program (condition × time interactions were observed), whereas group E did not show any improvement (Table IV) . Group A6 (5.7% ± 6.2% at 3 months; 5.9% ± 9.1% at 6 months) showed a signifi cant improvement in the 6M-W test (condition × time interactions were not observed) (Table IV) . Because the percentage changes in walking ability throughout the experiment did not show any signifi cant differences between the male and female participants, the data of the walking tests in the male and female participants were combined (Table IV) . Although groups A3 and A6 had improved walking ability, any signifi cant correlations between the increased extent of PMM CSA and the improved walking ability were not observed after the 6-month exercise program (Fig. 2) . 3-month -3.2 ± 3.4 -9.8 ± 7.2* † -12.7 ± 6.6* † † 6-month -4.0 ± 7.9 -13.6 ± 8.6** † -16.9 ± 7.2**# † † Kawada S et al. 3-month 0.1 ± 2.6 4.6 ± 3.7 † 5.7 ± 6.2* † 6-month -0.7 ± 4.9 3.3 ± 8.7 5.9 ± 9.1* PMM: the psoas major muscle. Values are expressed as means ± SD; n = 8 for group E, n = 10 for group A3, and n = 11 for group A6. *Signifi cantly different from values before the experiment (P < 0.05) and **(P < 0.01). #Signifi cantly different from values at 3 months. †Signifi cantly different from values of E group (P < 0.05) and † †(P < 0.01) Fig. 2 . No signifi cant correlations were observed between the increased extent of PMM CSA and improved walking ability in groups A3 and A6. Because the improvement in walking ability in groups A3 and A6 was roughly similar, the data of groups A3 and A6 were combined in each fi gure. 
Group
Discussion
The training program described here resulted in PMM hypertrophy and improved walking ability in groups A3 and A6. However, group E did not show any improvement in their walking ability regardless of PMM hypertrophy. In addition, no signifi cant correlations were observed between the increased extent of PMM CSA and the improved extent of walking ability after the 6-month exercise program in the amino acid administered participants. Ikezoe et al. reported that there was no correlation between PMM thickness and either a fast-walking (> 1 m/s) or a slow-walking (< 1 m/s) group of elderly people (10) . However, some of the participants in their study walked with assistive devices. The participants in this study were healthy and their maximum walking speed was higher than 1 m/s. These results suggest that PMM does not contribute signifi cantly to walking ability regardless of the health condition of elderly people.
As people walk, they must raise their feet to a certain height. Although this movement partially requires using PMM, our group E showed no improvement in walking ability regardless of PMM hypertrophy. It has been suggested that during sprint running, a larger PMM is important to produce an appropriate running speed as greater PMM strength enables a longer step length (8) . However, walking is entirely different from running as it involves contact of 1 foot with the ground so that there is a limitation to increase step length. Therefore, step length is considered less important for brisk walking than it is for sprint running, which implies that PMM hypertrophy may not lead directly to improved walking ability.
It has been observed that amino acid supplementation can increase muscle protein synthesis (12) . However, the extent of PMM hypertrophy was roughly similar in all groups in our study. Although it is unclear whether the training program combined with essential amino acid supplementation increased the size of other muscles, such as the thigh muscles, the amino acid supplementation used in our study may not have caused any additional effects on skeletal muscle hypertrophy. It has been reported that when dietary protein intake is at the recommended levels for individuals, additional protein intake from a supplement combined with resistance exercise does not have any additional effect on lean body mass (7) . The Ministry of Health, Labour and Welfare of Japan recommends > 50 g/day of protein intake for Japanese adult females and > 60 g/day for adult males. The protein intakes in our study participants exceeded these recommended levels. The nearly equivalent extent of PMM hypertrophy observed in our 3 groups may have been because of the suffi cient daily protein intake obtained from their meals.
Kim et al. reported that 3 g of a leucine-rich essential amino acid mixture taken twice a day for 3 months without any exercise training improved usual walking speed in elderly women, although leg muscle mass and knee extension strength did not increase (13) . In our study, the extent of PMM hypertrophy was not signifi cantly different between the 3 groups, although an improvement in walking ability was observed in groups A3 and A6, indicating that amino acids may have additional effects on improvements in walking ability. Although the precise mechanisms underlying the improvements in walking ability in groups A3 and A6 are uncertain, several possibilities exist. Cardiac function during exercise is a critical limiting factor for increasing the physical performance of elderly people. It has been demonstrated that 12 g/day of amino acid supplementation for 3 months resulted in signifi cant increases in 6-min walking distance and the peak stress left ventricular ejection fraction (LVEF) in elderly people without any exercise program (20) . It has also been demonstrated that 11 g of essential amino acids + arginine twice a day for 16 weeks increased lower extremity strength and improved normal and fast speed walking and endurance walking abilities without any training program (5). As peak stress LVEF and lower extremity strength were not measured in this study, it is uncertain whether the cardiac function and muscle strength of the participants in groups A3 and A6 improved to a greater extent than that of the participants in group E. However, the improvements in fast walking (10-W and 10-W + O) test results were similar in groups A3 and A6. Therefore, when essential amino acid supplementation is combined with an appropriate training program, the recommended amount of this supplementation to improve walking abilities for elderly people is 3 g/day and more.
Prior to our experiment, the mean values of 10-W, 10-W + O, and 6M-W tests in group E were the worst in all the groups, although the differences were not statistically signifi cant. However, the participants whose walking ability was in the upper half of E and almost equal to that in groups A3 and A6 showed no obvious improvement in their walking ability (data not shown). This implied that the difference in walking ability between the groups prior to the experiment did not infl uence the study results.
This study had several limitations. First, differences according to gender were not determined because of the small sample size. Further research should therefore include more participants, especially women. Second, only PMM CSA was measured in the study. Although we focused on the correlation between the increased extent of PMM CSA and improved extent of walking ability, the mechanisms underlying the improvement in walking ability in groups A3 and A6 could not be determined in this study. Thigh muscle CSA in all the groups needed to be measured to understand why group E did not show an improvement in walking ability regardless of PMM hypertrophy. Third, differences in cardiac function were not evaluated between the groups throughout the experiment. It has been shown that amino acid supplementation improves cardiac function without any physical exercise training and results in an increase in 6-min walking distance (20) . Fourth, in addition to group E, a group administered amino acids without any physical exercise training should have been provided as a control group to observe the effects of amino acid supplementation on walking ability. Fifth, although a 1-week questionnaire on daily food consumption was obtained from the participants before starting this study, the exact amino acid composition in each meal throughout the experimental period could not be determined. The effect of amino acid composition in each meal throughout the experiment period on the results of this study was therefore not confi rmed. Future research should analyze the exact amino acid composition in each meal.
In conclusion, the present study demonstrated that our training program for healthy elderly participants caused PMM hypertrophy independent of amino acid supplementation. However, only the groups that received essential amino acid supplements showed improved walking ability. To our knowledge, this is the fi rst study to demonstrate that essential amino acid supplementation at a dose of 3 g/day is adequate for elderly people to improve their walking ability when combined with an appropriate training program.
